Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
NTLA | Intellia Therapeutics, Inc. | EVP, Chief Business Officer | $2.19M | -$114K | -4.96% | Mar 1, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|